Skip to main content
. 2022 Oct 4;14(10):e29921. doi: 10.7759/cureus.29921

Table 2. Number of patients with treatment-related adverse events by the dose level of KLS-1.

Adverse events/toxicity signs Dose level (as per 64zinc)
0.2 mg/kg (n) 0.4 mg/kg (n) 0.6 mg/kg (n) 0.8 mg/kg (n)
Fatigue 2 4 1 -
Weakness 2 5 1 2
Dizziness 2 3 1 2
Headache 1 - - -
Chills - - - 1
Pain in the site of injection - - - 1
Poor sleep - - 1 2
Nausea - - 1 2
Abdominal discomfort - - - 2